PATENT CLAIM ANALYSIS

Application Number: 15742501
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "009400"]

Abstract:
A pharmaceutical composition for use in promoting wound healing and/or accelerating closure of an open wound in a subject in need thereof is disclosed. The composition comprises a therapeutically effective amount of a recombinant polypeptide comprising an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO: 2; and a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.

Claim (Index 12):
The method of  claim 1 , wherein the wound is at least one selected from the group consisting of diabetic foot ulcer, surgical wound, incision, laceration, abrasion, puncture wound, and crushing injury, or wherein the wound results from dermabrasion, first-degree burn, second-degree burn, third-degree burn, chemical burns or laser resurfacing.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14740194', '13646204', '14745562', '13975168', '14740158']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8057882712999136
- 35 USC 102 Novelty (BERT): 0.5191030705296831
- Combined Prediction Score: 0.7771197512228906
- Mean Citation Score: 265.7963680000001
- Max Citation Score: 268.07153
- Similarity Product: 144.24309183424472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test